Company
United StatesPublic company, NASDAQ: AGENAgenus Inc. (NASDAQ: AGEN), Lexington, MA – FDA Inspections
Inspection records and compliance data for Agenus Inc. in Lexington, Massachusetts. 1 FDA inspection on record, last inspected July 28, 2021. Publicly traded as NASDAQ: AGEN.
Company Profile
This profile covers Agenus Inc. based in Lexington, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected July 28, 2021.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 28, 2021 | NAI | Human Drugs · Bioresearch Monitoring | 1148029 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Agenus Inc.
Stock ticker
AGEN
Exchange
NASDAQ
Share price
$6.43
Market cap
$290.4M
Price as of
November 6, 2026
FEI Number
3010144196
Address
3 Forbes Rd, Lexington, Massachusetts 02421, United States
Country
United States
ID: 9a5afa02-1e12-4587-9bfa-6e9d2c0ab90e